The Implications of Marijuana Reclassification for the United States

The U.S. Drug Enforcement Administration is considering reclassifying marijuana to a less dangerous drug, moving it from Schedule I to Schedule III. President Joe Biden supports legalizing medical marijuana based on medical and scientific evidence. Rescheduling would not legalize recreational cannabis nationwide, as Schedule III drugs are still controlled substances. This change would impact research and marijuana business taxes, making it easier to study and reducing taxes for cannabis companies. However, critics argue that rescheduling is not enough and does not address the disparities in marijuana policies between states and the federal government.

Read more on apnews.com